Digene Corporation
Gaithersburg
About Digene Corporation
Digene Corporation is develops, manufactures, and markets proprietary gene-based diagnostic tests for the screening, monitoring, and diagnosis of human diseases with a focus on women’s cancers and infectious diseases worldwide. The company primarily offers human papillomavirus (HPV) testing products, which are FDA-approved tests for the detection of HPV, are a reproducible, objective test for the primary cause of cervical cancer. Its primary product is The Digene HPV Test, a FDA-approved test for HPV, the primary cause of cervical cancer.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Total funding: $103.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Nov 2005)
- Ticker: nasdaq:DIGE
- Website: digene.com
- Phone: (301) 944-7000
Industries & Categories
Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/digene-corporation-978168 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.